UA103268C2 - Пристрій регулювання повітряного потоку для порошкового інгалятора, що приводиться в дію вдиханням, деагломератор для порошкового інгалятора (варіанти), порошковий інгалятор, що приводиться в дію вдиханням (варіанти), та спосіб деагломерування сухого порошку в порошковому інгаляторі - Google Patents
Пристрій регулювання повітряного потоку для порошкового інгалятора, що приводиться в дію вдиханням, деагломератор для порошкового інгалятора (варіанти), порошковий інгалятор, що приводиться в дію вдиханням (варіанти), та спосіб деагломерування сухого порошку в порошковому інгаляторі Download PDFInfo
- Publication number
- UA103268C2 UA103268C2 UAA201206899A UAA201206899A UA103268C2 UA 103268 C2 UA103268 C2 UA 103268C2 UA A201206899 A UAA201206899 A UA A201206899A UA A201206899 A UAA201206899 A UA A201206899A UA 103268 C2 UA103268 C2 UA 103268C2
- Authority
- UA
- Ukraine
- Prior art keywords
- air flow
- channel
- vortex chamber
- inhalation
- control device
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims description 97
- 238000000034 method Methods 0.000 title claims description 16
- 229940112141 dry powder inhaler Drugs 0.000 title abstract 5
- 239000012530 fluid Substances 0.000 claims abstract description 30
- 238000004891 communication Methods 0.000 claims abstract description 26
- 230000002093 peripheral effect Effects 0.000 claims description 41
- 230000001105 regulatory effect Effects 0.000 claims description 26
- 239000003814 drug Substances 0.000 description 26
- 229940079593 drug Drugs 0.000 description 17
- 230000003434 inspiratory effect Effects 0.000 description 13
- 239000002245 particle Substances 0.000 description 11
- 239000005557 antagonist Substances 0.000 description 8
- 239000003112 inhibitor Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- -1 polypropylene Polymers 0.000 description 5
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 229940125715 antihistaminic agent Drugs 0.000 description 4
- 239000000739 antihistaminic agent Substances 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 230000013011 mating Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 3
- 150000003973 alkyl amines Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 239000003246 corticosteroid Substances 0.000 description 3
- 229960001334 corticosteroids Drugs 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 2
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- UFLGIAIHIAPJJC-UHFFFAOYSA-N Tripelennamine Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 UFLGIAIHIAPJJC-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002169 ethanolamines Chemical class 0.000 description 2
- 150000002171 ethylene diamines Chemical class 0.000 description 2
- 229960000289 fluticasone propionate Drugs 0.000 description 2
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 2
- 229960003088 loratadine Drugs 0.000 description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 229940044551 receptor antagonist Drugs 0.000 description 2
- 239000002464 receptor antagonist Substances 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229960003223 tripelennamine Drugs 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- PMGQWSIVQFOFOQ-BDUVBVHRSA-N (e)-but-2-enedioic acid;(2r)-2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine Chemical compound OC(=O)\C=C\C(O)=O.CN1CCC[C@@H]1CCOC(C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 PMGQWSIVQFOFOQ-BDUVBVHRSA-N 0.000 description 1
- JOROEVAWQLGPFQ-UHFFFAOYSA-N 1-benzhydryl-4-methylpiperazine;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.C1CN(C)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 JOROEVAWQLGPFQ-UHFFFAOYSA-N 0.000 description 1
- VSWPGAIWKHPTKX-UHFFFAOYSA-N 1-methyl-10-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]-5H-thieno[3,4-b][1,5]benzodiazepin-4-one Chemical compound C1CN(C)CCN1CC(=O)N1C2=CC=CC=C2NC(=O)C2=CSC(C)=C21 VSWPGAIWKHPTKX-UHFFFAOYSA-N 0.000 description 1
- PDNHLCRMUIGNBV-UHFFFAOYSA-N 1-pyridin-2-ylethanamine Chemical compound CC(N)C1=CC=CC=N1 PDNHLCRMUIGNBV-UHFFFAOYSA-N 0.000 description 1
- NVOYVOBDTVTBDX-AGUVMIOSSA-N 8g15t83e6i Chemical compound C1([C@@H](CO)C(=O)OC2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)CC)=CC=CC=C1 NVOYVOBDTVTBDX-AGUVMIOSSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241001106067 Atropa Species 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 102000017926 CHRM2 Human genes 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101150012960 Chrm2 gene Proteins 0.000 description 1
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- RRJFVPUCXDGFJB-UHFFFAOYSA-N Fexofenadine hydrochloride Chemical compound Cl.C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RRJFVPUCXDGFJB-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 description 1
- ZTVIKZXZYLEVOL-MCOXGKPRSA-N Homatropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(O)C1=CC=CC=C1 ZTVIKZXZYLEVOL-MCOXGKPRSA-N 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- DHUZAAUGHUHIDS-ONEGZZNKSA-N Isomyristicin Chemical compound COC1=CC(\C=C\C)=CC2=C1OCO2 DHUZAAUGHUHIDS-ONEGZZNKSA-N 0.000 description 1
- BFSMWENDZZIWPW-UHFFFAOYSA-N Isopropamide iodide Chemical compound [I-].C=1C=CC=CC=1C(C(N)=O)(CC[N+](C)(C(C)C)C(C)C)C1=CC=CC=C1 BFSMWENDZZIWPW-UHFFFAOYSA-N 0.000 description 1
- ZCGOMHNNNFPNMX-YHYDXASRSA-N Levocabastinum Chemical compound C1([C@@]2(C(O)=O)CCN(C[C@H]2C)C2CCC(CC2)(C#N)C=2C=CC(F)=CC=2)=CC=CC=C1 ZCGOMHNNNFPNMX-YHYDXASRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- OCJYIGYOJCODJL-UHFFFAOYSA-N Meclizine Chemical compound CC1=CC=CC(CN2CCN(CC2)C(C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 OCJYIGYOJCODJL-UHFFFAOYSA-N 0.000 description 1
- GZHFODJQISUKAY-UHFFFAOYSA-N Methantheline Chemical compound C1=CC=C2C(C(=O)OCC[N+](C)(CC)CC)C3=CC=CC=C3OC2=C1 GZHFODJQISUKAY-UHFFFAOYSA-N 0.000 description 1
- FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 description 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- HWHLPVGTWGOCJO-UHFFFAOYSA-N Trihexyphenidyl Chemical group C1CCCCC1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 HWHLPVGTWGOCJO-UHFFFAOYSA-N 0.000 description 1
- BGDKAVGWHJFAGW-UHFFFAOYSA-N Tropicamide Chemical compound C=1C=CC=CC=1C(CO)C(=O)N(CC)CC1=CC=NC=C1 BGDKAVGWHJFAGW-UHFFFAOYSA-N 0.000 description 1
- PWACSDKDOHSSQD-IUTFFREVSA-N acrivastine Chemical compound C1=CC(C)=CC=C1C(\C=1N=C(\C=C\C(O)=O)C=CC=1)=C/CN1CCCC1 PWACSDKDOHSSQD-IUTFFREVSA-N 0.000 description 1
- 229960003792 acrivastine Drugs 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000012387 aerosolization Methods 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940052651 anticholinergic tertiary amines Drugs 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- YEJAJYAHJQIWNU-UHFFFAOYSA-N azelastine hydrochloride Chemical compound Cl.C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 YEJAJYAHJQIWNU-UHFFFAOYSA-N 0.000 description 1
- 229960004335 azelastine hydrochloride Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- 229940092705 beclomethasone Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- GVNWHCVWDRNXAZ-BTJKTKAUSA-N carbinoxamine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(OCCN(C)C)C1=CC=C(Cl)C=C1 GVNWHCVWDRNXAZ-BTJKTKAUSA-N 0.000 description 1
- 229960000456 carbinoxamine maleate Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 229960003728 ciclesonide Drugs 0.000 description 1
- 229960002689 clemastine fumarate Drugs 0.000 description 1
- GKEGFOKQMZHVOW-KUTGSRRKSA-M clidinium bromide Chemical compound [Br-].C1([C@H]2CC[N@+](CC2)(C1)C)OC(=O)C(O)(C=1C=CC=CC=1)C1=CC=CC=C1 GKEGFOKQMZHVOW-KUTGSRRKSA-M 0.000 description 1
- 229960005098 clidinium bromide Drugs 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- UVKZSORBKUEBAZ-UHFFFAOYSA-N cyclizine Chemical compound C1CN(C)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 UVKZSORBKUEBAZ-UHFFFAOYSA-N 0.000 description 1
- 229960003564 cyclizine Drugs 0.000 description 1
- 229960002128 cyclizine lactate Drugs 0.000 description 1
- 229960001815 cyclopentolate Drugs 0.000 description 1
- SKYSRIRYMSLOIN-UHFFFAOYSA-N cyclopentolate Chemical compound C1CCCC1(O)C(C(=O)OCCN(C)C)C1=CC=CC=C1 SKYSRIRYMSLOIN-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 238000009513 drug distribution Methods 0.000 description 1
- 239000003602 elastase inhibitor Substances 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960000354 fexofenadine hydrochloride Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940015042 glycopyrrolate Drugs 0.000 description 1
- NSILVESQCSUIAJ-UHFFFAOYSA-M hexocyclium methyl sulfate Chemical compound COS([O-])(=O)=O.C1C[N+](C)(C)CCN1CC(O)(C=1C=CC=CC=1)C1CCCCC1 NSILVESQCSUIAJ-UHFFFAOYSA-M 0.000 description 1
- 229960001168 hexocyclium methylsulfate Drugs 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229960000857 homatropine Drugs 0.000 description 1
- ZQDWXGKKHFNSQK-UHFFFAOYSA-N hydroxyzine Chemical compound C1CN(CCOCCO)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZQDWXGKKHFNSQK-UHFFFAOYSA-N 0.000 description 1
- 229960000930 hydroxyzine Drugs 0.000 description 1
- 229960001560 hydroxyzine pamoate Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125369 inhaled corticosteroids Drugs 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000008011 inorganic excipient Substances 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 description 1
- 229960001888 ipratropium Drugs 0.000 description 1
- 229960001543 isopropamide iodide Drugs 0.000 description 1
- 229940112580 kovia Drugs 0.000 description 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
- 229960000582 mepyramine Drugs 0.000 description 1
- 229960001470 methantheline Drugs 0.000 description 1
- RPMBYDYUVKEZJA-UHFFFAOYSA-N methoctramine Chemical compound COC1=CC=CC=C1CNCCCCCCNCCCCCCCCNCCCCCCNCC1=CC=CC=C1OC RPMBYDYUVKEZJA-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229960001664 mometasone Drugs 0.000 description 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229960002259 nedocromil sodium Drugs 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940124624 oral corticosteroid Drugs 0.000 description 1
- 239000008012 organic excipient Substances 0.000 description 1
- 150000002990 phenothiazines Chemical class 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- RMHMFHUVIITRHF-UHFFFAOYSA-N pirenzepine Chemical compound C1CN(C)CCN1CC(=O)N1C2=NC=CC=C2NC(=O)C2=CC=CC=C21 RMHMFHUVIITRHF-UHFFFAOYSA-N 0.000 description 1
- 229960004633 pirenzepine Drugs 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229960005439 propantheline bromide Drugs 0.000 description 1
- 239000003379 purinergic P1 receptor agonist Substances 0.000 description 1
- 239000000296 purinergic P1 receptor antagonist Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229950004432 rofleponide Drugs 0.000 description 1
- IXTCZMJQGGONPY-XJAYAHQCSA-N rofleponide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3O[C@@H](CCC)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O IXTCZMJQGGONPY-XJAYAHQCSA-N 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229950004351 telenzepine Drugs 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 229960000351 terfenadine Drugs 0.000 description 1
- YUSMZDVTEOAHDL-NTMALXAHSA-N tert-butyl (3z)-3-(dimethylaminomethylidene)-4-oxopiperidine-1-carboxylate Chemical compound CN(C)\C=C1\CN(C(=O)OC(C)(C)C)CCC1=O YUSMZDVTEOAHDL-NTMALXAHSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 1
- 229940110309 tiotropium Drugs 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 229960001032 trihexyphenidyl Drugs 0.000 description 1
- 229960004791 tropicamide Drugs 0.000 description 1
- 239000002750 tryptase inhibitor Substances 0.000 description 1
- 229950000339 xinafoate Drugs 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/06—Containers or packages with special means for dispensing contents for dispensing powdered or granular material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Respiratory Apparatuses And Protective Means (AREA)
- Percussion Or Vibration Massage (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- External Artificial Organs (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0919465.5A GB0919465D0 (en) | 2009-11-06 | 2009-11-06 | Airflow adaptor for a breath-actuated dry powder inhaler |
| PCT/EP2010/006744 WO2011054527A1 (en) | 2009-11-06 | 2010-11-05 | Airflow adaptor for a breath-actuated dry powder inhaler |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA103268C2 true UA103268C2 (uk) | 2013-09-25 |
Family
ID=41501996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201206899A UA103268C2 (uk) | 2009-11-06 | 2010-05-11 | Пристрій регулювання повітряного потоку для порошкового інгалятора, що приводиться в дію вдиханням, деагломератор для порошкового інгалятора (варіанти), порошковий інгалятор, що приводиться в дію вдиханням (варіанти), та спосіб деагломерування сухого порошку в порошковому інгаляторі |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US8714149B2 (enExample) |
| EP (3) | EP2596827B1 (enExample) |
| JP (4) | JP5591941B2 (enExample) |
| KR (1) | KR101507648B1 (enExample) |
| CN (2) | CN102655902B (enExample) |
| AU (1) | AU2010314369B2 (enExample) |
| BR (1) | BR112012010354A2 (enExample) |
| CA (1) | CA2779347C (enExample) |
| DK (3) | DK2496294T3 (enExample) |
| EA (2) | EA024532B1 (enExample) |
| ES (3) | ES2620803T3 (enExample) |
| GB (1) | GB0919465D0 (enExample) |
| HR (1) | HRP20160106T1 (enExample) |
| HU (3) | HUE032058T2 (enExample) |
| IL (3) | IL219350A (enExample) |
| MX (2) | MX365477B (enExample) |
| NZ (3) | NZ599658A (enExample) |
| PE (1) | PE20130761A1 (enExample) |
| PL (3) | PL3002022T3 (enExample) |
| RS (1) | RS54562B1 (enExample) |
| SI (1) | SI2496294T1 (enExample) |
| SM (1) | SMT201600058B (enExample) |
| UA (1) | UA103268C2 (enExample) |
| WO (1) | WO2011054527A1 (enExample) |
| ZA (1) | ZA201203119B (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0910537D0 (en) | 2009-06-18 | 2009-07-29 | Ivax Pharmaceuticals Ireland | Inhaler |
| JP5785825B2 (ja) * | 2011-09-02 | 2015-09-30 | カヤバ工業株式会社 | ミキサ車 |
| CA2846899C (en) | 2011-09-07 | 2019-12-03 | Syphase, Llc | Dry powder inhalation device |
| USD740411S1 (en) * | 2012-09-21 | 2015-10-06 | Femasys Inc. | Device for pressure control |
| EP3021919B1 (en) * | 2013-07-16 | 2017-10-04 | Emphasys Importadora, Exportadora E Distribuidora De Embalagens Ltda. | Powder inhaler |
| US20150020806A1 (en) * | 2013-07-19 | 2015-01-22 | Merck Sharp & Dohme Corp. | Dry powder inhaler for delivering multipe agglomerate formulations |
| USD783159S1 (en) * | 2013-10-07 | 2017-04-04 | Teva Pharmaceutical Industries Limited | Respiratory apparatus |
| PE20160543A1 (es) * | 2013-10-07 | 2016-06-05 | Teva Branded Pharmaceutical Products Randd Inc | Inhalador de polvo seco que contiene fluticasona y salmeterol |
| USD783807S1 (en) * | 2013-10-07 | 2017-04-11 | Teva Pharmaceutical Industries Limited | Respiratory apparatus |
| AU355165S (en) * | 2013-10-07 | 2014-04-28 | Teva Uk Ltd | Respiratory apparatus |
| AU355166S (en) * | 2013-10-07 | 2014-04-28 | Teva Uk Ltd | Respiratory apparatus |
| AU355175S (en) * | 2013-10-07 | 2014-04-29 | Teva Uk Ltd | Respiratory apparatus |
| AU355051S (en) * | 2013-10-07 | 2014-04-16 | Teva Uk Ltd | Respiratory apparatus |
| AU355177S (en) * | 2013-10-07 | 2014-04-29 | Teva Uk Ltd | Respiratory apparatus |
| USD783151S1 (en) * | 2013-10-07 | 2017-04-04 | Teva Pharmaceutical Industries Limited | Respiratory apparatus |
| AU355168S (en) * | 2013-10-08 | 2014-04-29 | Teva Uk Ltd | Respiratory apparatus |
| USD783147S1 (en) * | 2013-10-08 | 2017-04-04 | Teva Pharmaceutical Industries Limited | Respiratory appartus |
| USD782647S1 (en) * | 2013-10-08 | 2017-03-28 | Teva Pharmaceutical Industries Limited | Respiratory apparatus |
| USD782653S1 (en) * | 2013-10-08 | 2017-03-28 | Teva Pharmaceutical Industries Limited | Respiratory apparatus |
| AU355172S (en) * | 2013-10-08 | 2014-04-29 | Teva Uk Ltd | Respiratory Apparatus |
| USD783152S1 (en) * | 2013-10-08 | 2017-04-04 | Teva Pharmaceutical Industries Limited | Respiratory apparatus |
| AU355204S (en) * | 2013-10-08 | 2014-05-02 | Teva Uk Ltd | Respiratory apparatus |
| USD783148S1 (en) * | 2013-10-08 | 2017-04-04 | Teva Pharmaceutical Industries Limited | Respiratory apparatus |
| AU355249S (en) * | 2013-10-08 | 2014-05-02 | Teva Branded Pharmaceutical Products R&D | Respiratory apparatus |
| AU355056S (en) * | 2013-10-08 | 2014-04-16 | Teva Uk Ltd | Respiratory apparatus |
| USD783155S1 (en) * | 2013-10-08 | 2017-04-04 | Teva Pharmaceutical Industries Limited | Respiratory apparatus |
| USD782648S1 (en) * | 2013-10-08 | 2017-03-28 | Teva Pharmaceutical Industries Limited | Respiratory apparatus |
| AU355203S (en) * | 2013-10-08 | 2014-05-01 | Teva Uk Ltd | Respiratory apparatus |
| AU355245S (en) * | 2013-10-08 | 2014-05-02 | Teva Branded Pharmaceutical Products R&D | Respiratory apparatus |
| AU355164S (en) * | 2013-10-08 | 2014-04-28 | Teva Uk Ltd | Respiratory apparatus |
| USD783149S1 (en) * | 2013-10-08 | 2017-04-04 | Teva Pharmaceutical Industries Limited | Respiratory apparatus |
| USD769436S1 (en) * | 2013-11-29 | 2016-10-18 | Norton (Waterford) Limited | Respiratory apparatus |
| USD769437S1 (en) * | 2013-11-29 | 2016-10-18 | Norton (Waterford) Limited | Respiratory apparatus |
| GB201321712D0 (en) | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Dry Powder Inhaler |
| US10561809B2 (en) * | 2014-06-06 | 2020-02-18 | Rijksuniversiteit Groningen | Breath actuated dry powder inhaler |
| IL287062B (en) | 2014-08-28 | 2022-08-01 | Norton Waterford Ltd | Compliance monitoring module for an inhaler |
| US9980904B2 (en) | 2014-10-16 | 2018-05-29 | Teva Branded Pharmaceutical Products R&D, Inc. | Dry powder formulation |
| AU2015331912A1 (en) | 2014-10-16 | 2017-05-25 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable formulation |
| US10058661B2 (en) | 2014-12-04 | 2018-08-28 | Norton (Waterford) Limited | Inhalation monitoring system and method |
| MA41378A (fr) | 2015-01-20 | 2017-11-28 | Teva Branded Pharmaceutical Prod R & D Inc | Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol |
| US11071837B2 (en) * | 2015-12-21 | 2021-07-27 | Kindeva Drug Delivery L.P. | Dose release firing systems and medicinal inhalers comprising same |
| USD852947S1 (en) | 2016-10-21 | 2019-07-02 | Norton (Waterford) Limited | Inhaler |
| USD832997S1 (en) | 2016-10-21 | 2018-11-06 | Norton (Waterford) Limited | Inhaler |
| USD832998S1 (en) | 2016-10-21 | 2018-11-06 | Norton (Waterford) Limited | Inhaler |
| USD853555S1 (en) | 2017-01-03 | 2019-07-09 | Norton (Waterford) Limited | Inhaler |
| GB201700727D0 (en) | 2017-01-16 | 2017-03-01 | Teva Pharma | Inhalers and airflow adaptors therefor |
| US10456537B2 (en) * | 2017-03-28 | 2019-10-29 | Concentrx Pharmaceuticals, Inc. | Devices and methods for delivering dry powder medicaments |
| WO2019060604A1 (en) | 2017-09-20 | 2019-03-28 | Teva Branded Pharmaceutical Products R&D, Inc. | INHALABLE MEDICINE |
| WO2019060595A1 (en) | 2017-09-20 | 2019-03-28 | Teva Branded Pharmaceutical Products R&D, Inc. | INHALABLE DRY POWDER MEDICINAL PRODUCT COMPRISING GLYCOPYRRONIUM |
| CN110201278B (zh) * | 2018-02-28 | 2021-07-30 | 张江 | 用于吸入给药的药盒和吸入给药组合结构 |
| CN111437473B (zh) * | 2020-04-16 | 2023-03-24 | 宁波诺丁汉大学 | 一种粉雾剂吸入装置 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2918408A (en) | 1957-04-08 | 1959-12-22 | Lakeside Lab Inc | Anti-spasmodic compositions specific for treating spasm of the colon |
| DE3429411C2 (de) * | 1984-08-09 | 1987-02-19 | Brugger, Inge, geb. Ritzau, 8130 Starnberg | Zerstäuberdüse |
| DE4211475A1 (de) * | 1991-12-14 | 1993-06-17 | Asta Medica Ag | Pulverinhalator |
| JP3320261B2 (ja) * | 1995-06-01 | 2002-09-03 | 株式会社ユニシアジェックス | 吸入式投薬器 |
| GB2312379B (en) * | 1996-04-25 | 1999-11-17 | Bespak Plc | Improved inhalers |
| JP3488620B2 (ja) * | 1998-02-05 | 2004-01-19 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
| JP2000217918A (ja) * | 1999-01-28 | 2000-08-08 | Unisia Jecs Corp | 吸入式投薬器 |
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| US7464706B2 (en) * | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
| EP1129705A1 (en) * | 2000-02-17 | 2001-09-05 | Rijksuniversiteit te Groningen | Powder formulation for inhalation |
| PE20020074A1 (es) * | 2000-06-23 | 2002-02-05 | Norton Healthcare Ltd | Sistema dosificador para inhalador de medicamento |
| TWI224511B (en) | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | De-agglomerator for breath-actuated dry powder inhaler |
| US6681768B2 (en) * | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
| DE10129703A1 (de) * | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
| JP2003215734A (ja) | 2002-01-28 | 2003-07-30 | Fuji Photo Film Co Ltd | 画像読取装置 |
| AU2003285770B2 (en) * | 2002-12-13 | 2009-03-12 | Otsuka Pharmaceutical Co., Ltd. | Inhalation device for transpulmonary administration |
| GB0303870D0 (en) * | 2003-02-20 | 2003-03-26 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
| US20060231096A1 (en) * | 2003-06-11 | 2006-10-19 | Hitachi, Ltd. | Inhalation type medication apparatus |
| PL1799289T3 (pl) * | 2004-09-16 | 2012-10-31 | Hollycon Italy Pte Ltd S R L | Jednorazowy inhalator jednodawkowy do sproszkowanych leków |
| GB0427856D0 (en) * | 2004-12-20 | 2005-01-19 | Glaxo Group Ltd | Maniflod for use in medicament dispenser |
| NZ576637A (en) * | 2006-10-25 | 2012-05-25 | Novartis Ag | Powder dispersion apparatus with and mediciment receptacles that are cut open using an elliptical arc shaped knife blade oriented to yaw between 4 and 12 degrees |
| HUE027246T2 (en) * | 2008-01-24 | 2016-10-28 | Vectura Delivery Devices Ltd | inhaler |
| EP2082764A1 (en) * | 2008-01-24 | 2009-07-29 | Boehringer Ingelheim International GmbH | Inhaler |
| GB0914738D0 (en) * | 2009-08-24 | 2009-09-30 | Cambridge Consultants | Inhalers |
-
2009
- 2009-11-06 GB GBGB0919465.5A patent/GB0919465D0/en not_active Ceased
-
2010
- 2010-05-11 UA UAA201206899A patent/UA103268C2/uk unknown
- 2010-11-05 MX MX2014012195A patent/MX365477B/es unknown
- 2010-11-05 NZ NZ599658A patent/NZ599658A/en unknown
- 2010-11-05 ES ES12196742.6T patent/ES2620803T3/es active Active
- 2010-11-05 PL PL15188339T patent/PL3002022T3/pl unknown
- 2010-11-05 NZ NZ627544A patent/NZ627544A/en unknown
- 2010-11-05 KR KR1020127012212A patent/KR101507648B1/ko not_active Expired - Fee Related
- 2010-11-05 MX MX2012005238A patent/MX2012005238A/es active IP Right Grant
- 2010-11-05 EA EA201290294A patent/EA024532B1/ru not_active IP Right Cessation
- 2010-11-05 AU AU2010314369A patent/AU2010314369B2/en not_active Ceased
- 2010-11-05 DK DK10779467.9T patent/DK2496294T3/en active
- 2010-11-05 CN CN201080049932.5A patent/CN102655902B/zh active Active
- 2010-11-05 ES ES15188339T patent/ES2707750T3/es active Active
- 2010-11-05 PL PL12196742T patent/PL2596827T3/pl unknown
- 2010-11-05 EA EA201690463A patent/EA035271B1/ru not_active IP Right Cessation
- 2010-11-05 JP JP2012537325A patent/JP5591941B2/ja not_active Expired - Fee Related
- 2010-11-05 HU HUE12196742A patent/HUE032058T2/en unknown
- 2010-11-05 RS RS20160098A patent/RS54562B1/sr unknown
- 2010-11-05 DK DK12196742.6T patent/DK2596827T3/en active
- 2010-11-05 SI SI201031132A patent/SI2496294T1/sl unknown
- 2010-11-05 PE PE2012000610A patent/PE20130761A1/es active IP Right Grant
- 2010-11-05 EP EP12196742.6A patent/EP2596827B1/en active Active
- 2010-11-05 HU HUE10779467A patent/HUE026876T2/en unknown
- 2010-11-05 CN CN201510156311.1A patent/CN104784790B/zh active Active
- 2010-11-05 DK DK15188339.4T patent/DK3002022T3/en active
- 2010-11-05 WO PCT/EP2010/006744 patent/WO2011054527A1/en not_active Ceased
- 2010-11-05 EP EP15188339.4A patent/EP3002022B1/en active Active
- 2010-11-05 HU HUE15188339A patent/HUE042305T2/hu unknown
- 2010-11-05 CA CA2779347A patent/CA2779347C/en not_active Expired - Fee Related
- 2010-11-05 BR BR112012010354A patent/BR112012010354A2/pt active Search and Examination
- 2010-11-05 EP EP10779467.9A patent/EP2496294B1/en active Active
- 2010-11-05 HR HRP20160106T patent/HRP20160106T1/hr unknown
- 2010-11-05 PL PL10779467T patent/PL2496294T3/pl unknown
- 2010-11-05 NZ NZ618744A patent/NZ618744A/en unknown
- 2010-11-05 ES ES10779467.9T patent/ES2563753T3/es active Active
- 2010-11-08 US US12/941,204 patent/US8714149B2/en active Active
-
2012
- 2012-04-22 IL IL219350A patent/IL219350A/en not_active IP Right Cessation
- 2012-04-30 ZA ZA2012/03119A patent/ZA201203119B/en unknown
-
2013
- 2013-07-24 US US13/949,679 patent/US10112020B2/en active Active
-
2014
- 2014-07-30 JP JP2014154593A patent/JP5931972B2/ja not_active Expired - Fee Related
- 2014-07-30 JP JP2014154592A patent/JP5931971B2/ja not_active Expired - Fee Related
-
2015
- 2015-10-06 IL IL241911A patent/IL241911A/en not_active IP Right Cessation
- 2015-10-06 IL IL241912A patent/IL241912A/en not_active IP Right Cessation
-
2016
- 2016-02-24 SM SM201600058T patent/SMT201600058B/xx unknown
- 2016-04-26 JP JP2016088132A patent/JP6403287B2/ja not_active Expired - Fee Related
- 2016-09-20 US US15/270,160 patent/US10195375B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA103268C2 (uk) | Пристрій регулювання повітряного потоку для порошкового інгалятора, що приводиться в дію вдиханням, деагломератор для порошкового інгалятора (варіанти), порошковий інгалятор, що приводиться в дію вдиханням (варіанти), та спосіб деагломерування сухого порошку в порошковому інгаляторі | |
| AU2018204860B2 (en) | Inhalable medicaments | |
| RU2757077C2 (ru) | Устройство введения ингаляционных лекарственных средств в виде сухого порошка с дозирующим механизмом сопротивления через сменные насадки | |
| CN111315432B (zh) | 吸入器和用于吸入器的网格 | |
| CN110177592B (zh) | 吸入器和用于吸入器的气流适配器 | |
| AU2014201778B2 (en) | Airflow adaptor for a breath-actuated dry powder inhaler | |
| HK1210441B (zh) | 用於呼吸致动的干粉吸入器的气流适配器 | |
| HK40006223A (en) | Inhalers and airflow adaptors therefor | |
| HK1210440B (zh) | 用於呼吸致动的干粉吸入器的气流适配器 | |
| HK1222150B (en) | Airflow adaptor for a breath-actuated dry powder inhaler |